NIH #R01CA303137
Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma
Active
- Amount
- $700K–$800K
- Period
- 2026-06-05 → 2031-05-31
- PIs
- 2
Awarded at DANA-FARBER CANCER INST
Rameen Beroukhim
Associate Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index34
i10-index39
Publications60
Citations42,193
Grants
8 total · 2 active
NIH #R01CA262462
Synthetic lethalities to cell cycle disruption in glioma
Active
- Amount
- $600K–$700K
- Period
- 2022-05-13 → 2027-04-30
- PIs
- 2
Awarded at DANA-FARBER CANCER INST
NIH #U24CA264029
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing Data
- Amount
- $300K–$400K
- Period
- 2021-09-20 → 2026-08-31
- PIs
- 2
Awarded at BROAD INSTITUTE, INC.
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Processed sequencing data for KRAS deep mutational scanning (variantCounts and aaCounts) (Figshare)2026-06-30
- New NIH award: Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma2026-06-05
- New preprint: Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity2024-10-25
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current